Bromantane administration in therapeutic doses is characterized from the Virtually total absence of Unwanted effects such as manifestations of withdrawal syndrome and hyperstimulation (Morozov et alEthomersol displays Qualities of the central action vasodilator in blocking the opportunity-dependent and specially the receptor-dependent calcium chann